Market Trends of Europe Contraceptives Industry
Condoms are Expected to Witness Significant Growth in the Market Over the Forecast Period
Condom use has significantly increased in adolescents due to easy availability and convenience. Furthermore, adequate protection from sexually transmitted infections and demand from the young population to enhance their sexual experience is expected to aid the product demand.
The rising initiatives from European countries on contraception for their residents are expected to drive the growth of this segment in Europe. For instance, in December 2022, an announcement was made by the President of France that stated young people in France would be able to get condoms free of charge from 2023 to reduce the spread of sexually transmitted diseases (STDs). The France health authorities also reported that the rate of STDs increased by about 30% in 2021 in France due to government initiatives and further decreased by the government enabling free condoms initiatives for young people in the country.
Moreover, according to the study published in the Journal of Scientific Research, in January 2022, in the United Kingdom, CSD500, a novel condom, appears to hold significant potential for its role as a condom that could improve men's and women's sexual pleasure. Thus, the availability of such condoms may increase the use of such condoms. Such studies are expected to drive this segment's growth further. In addition, the availability of different variants under the brands with high-quality standards, cost-effectiveness, and easy access from supermarkets, drug stores, and e-commerce platforms paved the way for this verticle.
Furthermore, the increasing use cases of STDs reported in European countries is also increasing the demand for condoms, thus driving this segment's growth. For instance, an article published by NCBI in May 2022 reported that a study conducted in France stated that syphilis prevalence and incidence were relatively high in France, especially among males who have sex with males with controlled HIV infection and pre-exposure prophylaxis users. The study also recommended that syphilis screening should be increased and behavioral risk reduction counseling among high-risk subjects should be conducted. Condoms are one of the essential requirements to lower the cases of sexually transmitted diseases; thus, increasing the chances of syphilis is driving the growth of this segment. Therefore, raising awareness among young adults about contraceptives and rising government initiatives are driving the development of this segment.
United Kingdom Expected to Witness Significant Growth in the Market Over the Forecast Period.
The United Kindom is expected to hold a significant share due to the rise in sexually transmitted diseases, initiatives taken by the key market players to launch new products, and the increasing number of unintended pregnancies. For instance, according to the Government of United Kingdom data published in November 2022, reported that 88.7 thousand HIV cases were reported in the United Kingdom in the year previous year, and this number is expected to increase to 91.4 thousand in the year 2021. The increasing HIV cases are constantly demanding for increasing use of contraceptives and thus driving the growth of the studied market.
Moreover, the increasing cases of unintended pregnancies leading to abortions drive the growth of the studied market in the country. For instance, in December 2021, statistics published by the United Kingdom government reported 214,256 abortions in England and Wales in 2021. In addition, the same source also said that 89% of abortions were performed in women under ten weeks in 2021 compared to 88% in the previous year. Thus, the rising number of abortions in the country is expected to increase the demand for contraceptive devices among the population, thereby propelling market growth.
Furthermore, in July 2021, HRA Pharma Consumer Healthcare company received authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) for the launch of the first type of contraceptive pill that will be available to buy in the United Kingdom without a prescription following a pharmacist consultation, that make it easier for some women to access and therefore use. In addition, in July 2021, United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) also granted Maxwellia's Lovina, a contraceptive pill that can be sold over the counter without a prescription. These authorizations in the United Kingdom are anticipated to drive market growth in this region due to the rise in the adoption of contraceptives. Thus, due to growing STDs, unintended pregnancies leading to abortion, regulatory approvals in the country, and increasing awareness about contraceptives, the market studied are expected to witness significant growth in the United Kingdom.
